N-Methylated Sst2 Selective Somatostatin Cyclic Peptide Analogue As a Potent Candidate for Treating Neurogenic Inflammation
Overview
Authors
Affiliations
A focused multiply N-methylated library of a cyclic hexapeptidic somatostatin analogue: MK678 cyclo(-MeAYwKVF-) was generated, which resulted in the unexpected observation of an efficacious tetra-N-methylated analogue, cyclo(-MeAYMewMeKVMeF-) with a potent inhibitory action on sensory neuropeptide release in vitro and on acute neurogenic inflammatory response in vivo. The analogue shows selectivity toward somatostatin receptor subtype 2 (sst2). Extensive 2D NMR spectroscopy and molecular dynamics simulation revealed the solution conformation of the analogue, which can be adopted as a lead for the further structure-activity relationship studies targeting neurogenic inflammation.
Suto B, Kolumban B, Szabo E, Pasztor S, Nemeth T, Bagoly T Biomedicines. 2023; 11(8).
PMID: 37626651 PMC: 10452449. DOI: 10.3390/biomedicines11082154.
Insights into structure-activity relationships of somatostatin analogs containing mesitylalanine.
Martin-Gago P, Aragon E, Gomez-Caminals M, Fernandez-Carneado J, Ramon R, Martin-Malpartida P Molecules. 2013; 18(12):14564-84.
PMID: 24287991 PMC: 6270305. DOI: 10.3390/molecules181214564.
Synthesis of N-methylated cyclic peptides.
Chatterjee J, Laufer B, Kessler H Nat Protoc. 2012; 7(3):432-44.
PMID: 22322216 DOI: 10.1038/nprot.2011.450.